Drug intelligence / Profile preview

Ruhe Sanjie Tablets

Development stage: Unknown
Lead developer: Guangzhou Baiyunshan Zhongyi Pharmaceutical
Administration: Oral

Overview

Ruhe Sanjie Tablets is a Traditional Chinese Medicine (TCM) herbal formulation developed and manufactured by Guangzhou Baiyun Mountain Zhongyi Pharmaceutical. It is primarily indicated for the treatment of breast hyperplasia (mastopathy) and associated symptoms such as breast lumps and mastalgia (breast pain). According to TCM principles, the formulation is designed to soothe the liver, resolve phlegm, and dissipate nodules. It is an approved commercial product in China and is widely utilized in gynecological clinical practice for the management of benign breast disorders.

Brand names: Ruhe Sanjie
Other names: Ruhe Sanjie Pian乳和散结片

Beyond the preview

Go deeper on Ruhe Sanjie Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ruhe Sanjie Tablets.

Explore the full profile